Sarepta Therapeutics, Inc. (SRPT) Social Stream



Sarepta Therapeutics, Inc. (SRPT): $114.23

3.73 (+3.38%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add SRPT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#44 of 333

in industry

Featured Post From StockTwits About SRPT

$SRPT SLDB is trash, CAPR needs funding for their program bc they don't want to take the risk themselves or they don't know wtf they are doing and need real experts in the field to take the reins. PFE is on hold by the FDA and has never been forthright with their testing methods, copied the same path we took,( w a worse vector and inferior tech) and they are avoiding head to head comparisons w SRPT at all costs. Now, renowned srpt hater Ellis Unger has been sent packing, one of biggest corrupt slimeball bp schills that's ever existed! SRPT is the DMD champ and the picture keeps getting clearer!
flexdiggs, published August 13, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!